Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9570328rdf:typepubmed:Citationlld:pubmed
pubmed-article:9570328lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:9570328lifeskim:mentionsumls-concept:C0000970lld:lifeskim
pubmed-article:9570328lifeskim:mentionsumls-concept:C0235378lld:lifeskim
pubmed-article:9570328pubmed:issue2-3lld:pubmed
pubmed-article:9570328pubmed:dateCreated1998-5-13lld:pubmed
pubmed-article:9570328pubmed:abstractTextThe role of metallothionein (MT) in protecting the liver against paracetamol (PCT) toxicity was investigated in vivo and in vitro in mice lacking expression of MT-1 and MT-2 genes (MT -/-). In the fed, glycogen replete state, hepatotoxicity (PCT 300 mg/kg i.p.) at 6 h was significantly greater in MT -/- than MT +/+ mice. Plasma lactate dehydrogenase (LD) and alanine aminotransferase (ALT) were 5- and 13-fold greater respectively than in MT +/+ mice. Liver glycogen, glucose and zinc levels were significantly lower in MT -/- mice at this time. In contrast, hepatotoxicity (PCT 135 mg/kg i.p.) at 6 h was similar in both MT +/+ and MT -/- mice fasted 24 h, despite a doubling in liver MT in MT +/+ mice. No differences were found between MT -/- and MT +/+ mice in cytochrome P450 activity. Liver glutathione levels were the same in both groups of mice prior to fasting and were decreased to a similar extent (55-65%) following PCT treatment. Investigation of lower PCT doses (< or = 120 mg/kg) in fasted mice over 24 h demonstrated a greater susceptibility in female MT -/- mice with plasma LD, 2.4-fold and ALT, 7.5-fold greater than in MT +/+ mice at 120 mg/kg PCT. In male MT -/- mice, there was only a trend towards greater susceptibility at 110 mg/kg PCT compared to male MT +/+ mice, and at 120 mg/kg, both male genotypes were equally affected. Investigations with cultured hepatocytes supported the in vivo findings in that there was a trend towards greater toxicity (PCT at 1 and 5 mM for 24 h) in hepatocytes from fed MT -/- mice, with the difference diminished in association with greater hepatotoxicity in hepatocytes from fasted mice. Use of dexamethasone (Dex) to increase MT in the MT +/+ mouse hepatocytes protected from PCT toxicity. Zn alone was not protective. Zn plus Dex offered no protection despite higher MT levels. Generation of apo-MT with Dex may offer more protection than Zn-MT. In conclusion, MT -/- mice were more susceptible than MT +/+ mice to PCT toxicity in the fed state, but the increased susceptibility was much smaller, but still significant, when the effects of glycogen were minimised by fasting.lld:pubmed
pubmed-article:9570328pubmed:languageenglld:pubmed
pubmed-article:9570328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570328pubmed:citationSubsetIMlld:pubmed
pubmed-article:9570328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570328pubmed:statusMEDLINElld:pubmed
pubmed-article:9570328pubmed:monthFeblld:pubmed
pubmed-article:9570328pubmed:issn0300-483Xlld:pubmed
pubmed-article:9570328pubmed:authorpubmed-author:CoylePPlld:pubmed
pubmed-article:9570328pubmed:authorpubmed-author:RofeA MAMlld:pubmed
pubmed-article:9570328pubmed:authorpubmed-author:BarryE FEFlld:pubmed
pubmed-article:9570328pubmed:authorpubmed-author:PhilcoxJ CJClld:pubmed
pubmed-article:9570328pubmed:authorpubmed-author:SheltonT LTLlld:pubmed
pubmed-article:9570328pubmed:issnTypePrintlld:pubmed
pubmed-article:9570328pubmed:day6lld:pubmed
pubmed-article:9570328pubmed:volume125lld:pubmed
pubmed-article:9570328pubmed:ownerNLMlld:pubmed
pubmed-article:9570328pubmed:authorsCompleteYlld:pubmed
pubmed-article:9570328pubmed:pagination131-40lld:pubmed
pubmed-article:9570328pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:meshHeadingpubmed-meshheading:9570328-...lld:pubmed
pubmed-article:9570328pubmed:year1998lld:pubmed
pubmed-article:9570328pubmed:articleTitleParacetamol hepatotoxicity in metallothionein-null mice.lld:pubmed
pubmed-article:9570328pubmed:affiliationDivision of Clinical Biochemistry, Institute of Medical and Veterinary Science, Adelaide, Australia.lld:pubmed
pubmed-article:9570328pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9570328pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9570328lld:pubmed